Prostate cancer screenings slash the risk of dying from the disease in the following decades, according to new research.
The screening measures the amount of prostate-specific antigen (PSA) in men’s blood. If they have abnormal results, doctors typically recommend biopsies and additional testing to make a prostate cancer diagnosis.
The study, which was published in the New England Journal of Medicine, indicates that PSA tes
Continue Reading on Euronews
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.